Product Information

OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB is a generic product labeled by NorthStar Rx LLC, priced at $0.2214 per EA under NDC 72603029202. Its NADAC has been published 47 times since Oct 1, 2025.

FDA first approved this application on Jun 1, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB

OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE
$0.2214per EA

Strength

25; 40 mg/1; mg/1

Manufacturer

NorthStar Rx LLC

NDC

72603029202

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA204801

FDA Approved

6/1/2023

TE Code

AB

On Market Since

4/8/2024

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB has been published 47 times since Oct 1, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.2214 per EA
All-time high$0.2343 (Jun 10, 2026)
All-time low$0.2023 (Feb 18, 2026)
52-week high$0.2343
52-week low$0.2023
Median price$0.2159
Average price$0.2177
Largest weekly change+6.7% (Mar 18, 2026)
Weeks tracked47
Tracking sinceOct 1, 2025

Price History

1W

-1.2%

1M

-1.2%

3M

-5.5%

6M

+9.4%

1Y

N/A

3Y

N/A

5Y

N/A

All

+1.6%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB, manufactured by NorthStar Rx LLC, is $0.2214 per EA (NDC 72603029202), effective Aug 19, 2026.

How has the price of OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB changed over time?

Over the history we have for it, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB has held within roughly two percent of its current level. It has been tracked across 47 weekly CMS publications since Oct 1, 2025.

What are the highest and lowest recorded NADAC prices for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB?

Since Oct 1, 2025, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB has ranged from a low of $0.2023 (Feb 18, 2026) to a high of $0.2343 (Jun 10, 2026), with a median of $0.2159 per EA.

Are there cheaper alternatives to OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB?

OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB (NDC 72603029202) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.